Pharmacy Board of Australia v Wang

Link copied
Case Copied 21 min read

ACT CIVIL & ADMINISTRATIVE TRIBUNAL



PHARMACY BOARD OF AUSTRALIA v WANG

(Occupational Discipline) [2015] ACAT 70

OR 15/23

Catchwords:              OCCUPATIONAL DISCIPLINE – health practitioner regulation – pharmacist – unprofessional conduct due to dispensing of incorrect medication – consent orders reached - significant delay between conduct and hearing

Legislation:ACT Civil and Administrative Tribunal Act 2008 (ACT) s 55

Health Practitioner Regulation National Law (ACT) s 3, 191, 193, 196

Cases Cited:Pharmacy Board of Australia v Fitzpatrick [2012] QCAT 552
Pharmacy Board of Australia v Jattan [2015] QCAT 294

R v Robertson (2007) 177 A Crim R 121

Health Care Complaints Commission (NSW) v Black [2014] NSWCATOD 35
Bar-Mordecai v Medical Council (NSW) [2014] NSWCATOD 142

XG v Medical Board of Australia [2011] VSC 638

Tribunal:                   Ms M Brennan – Senior Member

Date of Orders:  22 September 2015                 

Date of Reasons for Decision:      19 October 2015

ACT CIVIL & ADMINISTRATIVE TRIBUNAL           OR 15/23

BETWEEN:

PHARMACY BOARD OF AUSTRALIA

Applicant

AND:

MANDY WANG

Respondent

TRIBUNAL:             Ms M Brennan- Senior Member

DATE:22 September 2015     

ORDER

The Tribunal Orders that:

  1. The agreed draft Orders proposed by the parties on 22 September 2015 are made pursuant to section 55 of the ACT Civil Administrative Tribunal Act 2008 (the ACAT Act).



  2. The terms of agreement are:

    a)Pursuant to section 196(1) of the Health Practitioner Regulation National Law (ACT) (the National Law) the respondent has behaved in a way that constitutes unprofessional conduct; and

    b)Pursuant to section 196(2) of the National Law the respondent is reprimanded; and

    c)Pursuant to section 196(2) of the National Law the following conditions are imposed on the respondent’s registration as a pharmacist:

    i.The practitioner undertakes the Ethics and Dispensing in Pharmacy Practice course offered by the Pharmaceutical Society of Australia. Completion of the course is to be funded by the practitioner.

    ii.The practitioner is to provide evidence of enrolment in the Ethics and Dispensing in Pharmacy course within 28 days of the imposition of the conditions.

    iii.The practitioner is to complete the Ethics and Dispensing in Pharmacy Practice course within 9 months of the imposition of these conditions. Evidence of successful completion of the course is to be provided to the Board no more than 28 days after the course is completed.

  3. The names of the notifier and consumer of the wrongly dispensed medication in this matter are to be suppressed. The latter will be referred to as customer A.

………………………………..

Ms M. Brennan – Senior Member

REASONS FOR DECISION

  1. In making orders pursuant to section 55 of the ACT Civil and Administrative Tribunal Act 2008, the Tribunal must be satisfied that the orders proposed are within the Tribunal’s powers and appropriate for the Tribunal to make.

  2. Sub-section 196(1)(b)(ii) of the National Law empowers the Tribunal to decide that a practitioner has behaved in a way that constitutes unprofessional conduct.

  3. Sub-section 196(2) details the Tribunal’s powers after it makes a finding under sub-section 196(1)(b). These include reprimanding the practitioner and imposing a range of conditions on the practitioner’s registration,…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Pharmacy Board of Australia v Wang and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2015] ACAT 70
Decision Date

CaseChat Overview and Summary

In the matter of Pharmacy Board of Australia v Wang, the respondent, a pharmacist, was found to have dispensed the wrong medication, leading to a serious health incident for a patient, subsequently referred to as Customer A. The Tribunal was tasked with considering the consent orders proposed by the parties, which acknowledged the unprofessional conduct of the respondent and imposed conditions on her registration as a pharmacist, including mandatory training and course completion. The Tribunal's role was to ensure the respondent understood the gravity of the situation and the steps necessary to mitigate future risks, while also providing an opportunity for the parties to reach a resolution without a formal hearing.

The primary legal issues before the Tribunal were whether the respondent's actions constituted unprofessional conduct under the Health Practitioner Regulation National Law (ACT) and, if so, what appropriate conditions should be imposed on her registration. The consent orders proposed by the parties acknowledged the unprofessional conduct and stipulated conditions for the respondent's continued practice. The Tribunal needed to assess whether these conditions were sufficient to address the respondent's conduct and protect public safety, while also considering the interests of all parties involved.

The Tribunal reviewed the agreed statement of facts and found that the respondent had indeed dispensed incorrect medication to Customer A, leading to significant health complications. The Tribunal noted that the respondent had taken steps to understand the incident and had agreed to undertake specific training to prevent future errors. The Tribunal concluded that the proposed conditions, including mandatory ethics and dispensing training, were appropriate to address the respondent's conduct and ensure public safety. The Tribunal made the agreed draft Orders pursuant to section 55 of the ACT Civil Administrative Tribunal Act 2008, imposing the conditions on the respondent's registration and suppressing the names of the involved parties.

The Tribunal made the agreed draft Orders pursuant to section 55 of the ACT Civil Administrative Tribunal Act 2008, imposing the conditions on the respondent's registration and reprimanding the respondent for her unprofessional conduct. The conditions required the respondent to complete the Ethics and Dispensing in Pharmacy Practice course offered by the Pharmaceutical Society of Australia, with evidence of completion to be provided to the Board. These orders were designed to ensure the respondent understood the seriousness of her actions, took steps to rectify them, and minimised the risk of future incidents.

Orders

Orders of the court

1. The agreed draft Orders proposed by the parties on 22 September 2015 are made pursuant to section 55 of the ACT Civil Administrative Tribunal Act 2008 (the ACAT Act).

2. The terms of agreement are:

a) Pursuant to section 196(1) of the Health Practitioner Regulation National Law (ACT) (the National Law) the respondent has behaved in a way that constitutes unprofessional conduct; and

b) Pursuant to section 196(2) of the National Law the respondent is reprimanded; and

c) Pursuant to section 196(2) of the National Law the following conditions are imposed on the respondent’s registration as a pharmacist:

i. The practitioner undertakes the Ethics and Dispensing in Pharmacy Practice course offered by the Pharmaceutical Society of Australia. Completion of the course is to be funded by the practitioner.

ii. The practitioner is to provide evidence of enrolment in the Ethics and Dispensing in Pharmacy course within 28 days of the imposition of the conditions.

iii. The practitioner is to complete the Ethics and Dispensing in Pharmacy Practice course within 9 months of the imposition of these conditions. Evidence of successful completion of the course is to be provided to the Board no more than 28 days after the course is completed.

3. The names of the notifier and consumer of the wrongly dispensed medication in this matter are to be suppressed. The latter will be referred to as customer A.

Background

Background to the litigation

Finally, it is in the interests of the parties and the wider community that this matter could be resolved without requiring a hearing. In making a consent order of this kind the Tribunal had the opportunity to review and comment upon the consent orders proposed. There was also the opportunity to review the agreed statement of facts with the registered health practitioner in order to confirm her understanding of the importance of the matter and what steps she had taken to ensure the future risks of dispensing errors were minimised. ………………………………..Ms M Brennan - Senior MemberSTATEMENT OF AGREED FACTS The respondent is a registered pharmacist, having been first registered provisionally to practice pharmacy on 18 January 2011. Her current general registration will expire on 30 November 2015 (Document 1). The respondent has no conditions on her registration. The respondent completed her undergraduate qualification at Charles Sturt University, Wagga NSW, and she holds a Bachelor of Pharmacy degree. The respondent has been employed as a pharmacist:(a) from 13 December 2010 at The Chemist Warehouse, Phillip;(b) from 18 October 2013 at The Chemist Warehouse, Queanbeyan; and(c) from 4 November 2014 at The Chemist Warehouse, Majura Park. B. RESPONDENT’S REGISTRATION HISTORY The respondent was first registered on a provisional basis (supervised practice) on 18 January 2011. The respondent became eligible to apply for general registration on 22 February 2012 after passing the Pharmacy Board of Australia (the Board) oral examination. The respondent was granted full registration as a pharmacist on 5 April 2012. On 8 June 2012, the Australian Health Practitioner Regulation Agency (AHPRA) received a notification from Customer A’s agent regarding the respondent’s practice of pharmacy (Customer A Notification) (Document 2). Customer A agent’s notification contained the following allegations:(a)that she had submitted a prescription at The Chemist Warehouse in Phillip, ACT on 14 May 2012 where the respondent was the pharmacist on duty;(b)that she had submitted the prescription on behalf of her husband, Customer A;(c)the prescription was issued to Customer A by his renal specialist, Dr Krishna Karpe on 13 May 2012, and was for the diuretic Lasix at a dosage of 250mg twice daily;(d)Customer A had suffered from chronic kidney failure from the age of three weeks, and had undergone a kidney transplant in 2002;(e)the medication dispensed in accordance with Dr Karpe’s prescription was Digoxin. The label on the medication from The Chemist Warehouse instructed Customer A to take 250mcg of Digoxin twice daily;(f)Digoxin is a medication used to slow a person’s heart rate. Customer A’s agent stated that she has since been advised by a doctor that Digoxin is not commonly prescribed, particularly in the dose it was dispensed to Customer A, because Digoxin is “toxic”;(g)Customer A began to take the Digoxin provided from The Chemist Warehouse in Phillip as directed on the medication label;(h)On 20 May 2012, Customer A began to experience vomiting and diarrhoea;(i)By 25 May 2012, Customer A had no improvement in his symptoms so Customer A’s agent took him to the Emergency Department at The Canberra Hospital (TCH);(j)When Customer A was seen by the doctors at TCH, it became apparent that Digoxin had been dispensed to Customer A in error;(k)Customer A was diagnosed with Digoxin Toxicity and was administered five vials of Digibind (an antidote to Digoxin);(l)The dosage directions on the Digoxin given to Customer A was four times the recommended dose for a patient with renal impairment;(m)Customer A had some kidney functioning tests on 25 May 2012 at TCH which suggested that the Digoxin had had a detrimental impact on Customer A’s kidney functioning and brought forward the need to begin dialysis;(n)Customer A was subsequently admitted to the Critical Care Unit within the Cardiology Ward at TCH;(o)Customer A was discharged from TCH on the afternoon of 26 May 2012 and advised to return to the TCH Emergency Department if his condition deteriorated;(p)Customer A attended his GP on 28 May 2012 and further blood tests were ordered to check the Digoxin levels in Customer A’s body;(q)Customer A had further blood tests on 30 May 2012 which showed his Digoxin levels were still in the “high” range;(r)Due to his ingestion of Digoxin, Customer A required two weeks away from work on sick leave. He returned to work part-time on 4 June 2012;(s)On 4 June 2012, Customer A’s blood tests showed that his Digoxin levels had decreased to an almost “normal” level; (t)Customer A began dialysis on 6 June 2012; and(u)If Customer A had continued taking Digoxin as directed on the medication label and without medical intervention, his symptoms would have become much more acute and could have been fatal.

Decision

Reasons for decision

Issues
1. Has the respondent behaved in a way that constitutes unprofessional conduct?
2. What are the appropriate conditions to be imposed on the respondent's registration as a pharmacist?

Held
1. The court held that the respondent's conduct constituted unprofessional conduct, as agreed by the parties and pursuant to section 196(1) of the Health Practitioner Regulation National Law (ACT).
2. The court held that the respondent is to be reprimanded, as agreed by the parties and pursuant to section 196(2) of the National Law.
3. The court held that the following conditions are to be imposed on the respondent's registration as a pharmacist, as agreed by the parties and pursuant to section 196(2) of the National Law: (i) the respondent must undertake the Ethics and Dispensing in Pharmacy Practice course offered by the Pharmaceutical Society of Australia, with completion to be funded by the practitioner; (ii) the respondent must provide evidence of enrolment in the course within 28 days of the imposition of the conditions; and (iii) the respondent must complete the course within 9 months of the imposition of these conditions, with evidence of successful completion to be provided to the Board no more than 28 days after the course is completed.

Ratio Decidendi

Legal Principle Established

The respondent has been employed as a pharmacist:(a) from 13 December 2010 at The Chemist Warehouse, Phillip;(b) from 18 October 2013 at The Chemist Warehouse, Queanbeyan; and(c) from 4 November 2014 at The Chemist Warehouse, Majura Park. B. RESPONDENT’S REGISTRATION HISTORY The respondent was first registered on a provisional basis (supervised practice) on 18 January 2011. The respondent became eligible to apply for general registration on 22 February 2012 after passing the Pharmacy Board of Australia (the Board) oral examination. The respondent was granted full registration as a pharmacist on 5 April 2012. On 8 June 2012, the Australian Health Practitioner Regulation Agency (AHPRA) received a notification from Customer A’s agent regarding the respondent’s practice of pharmacy (Customer A Notification) (Document 2). Customer A agent’s notification contained the following allegations:(a)that she had submitted a prescription at The Chemist Warehouse in Phillip, ACT on 14 May 2012 where the respondent was the pharmacist on duty;(b)that she had submitted the prescription on behalf of her husband, Customer A;(c)the prescription was issued to Customer A by his renal specialist, Dr Krishna Karpe on 13 May 2012, and was for the diuretic Lasix at a dosage of 250mg twice daily;(d)Customer A had suffered from chronic kidney failure from the age of three weeks, and had undergone a kidney transplant in 2002;(e)the medication dispensed in accordance with Dr Karpe’s prescription was Digoxin. The label on the medication from The Chemist Warehouse instructed Customer A to take 250mcg of Digoxin twice daily;(f)Digoxin is a medication used to slow a person’s heart rate. Customer A’s agent stated that she has since been advised by a doctor that Digoxin is not commonly prescribed, particularly in the dose it was dispensed to Customer A, because Digoxin is “toxic”;(g)Customer A began to take the Digoxin provided from The Chemist Warehouse in Phillip as directed on the medication label;(h)On 20 May 2012, Customer A began to experience vomiting and diarrhoea;(i)By 25 May 2012, Customer A had no improvement in his symptoms so Customer A’s agent took him to the Emergency Department at The Canberra Hospital (TCH);(j)When Customer A was seen by the doctors at TCH, it became apparent that Digoxin had been dispensed to Customer A in error;(k)Customer A was diagnosed with Digoxin Toxicity and was administered five vials of Digibind (an antidote to Digoxin);(l)The dosage directions on the Digoxin given to Customer A was four times the recommended dose for a patient with renal impairment;(m)Customer A had some kidney functioning tests on 25 May 2012 at TCH which suggested that the Digoxin had had a detrimental impact on Customer A’s kidney functioning and brought forward the need to begin dialysis;(n)Customer A was subsequently admitted to the Critical Care Unit within the Cardiology Ward at TCH;(o)Customer A was discharged from TCH on the afternoon of 26 May 2012 and advised to return to the TCH Emergency Department if his condition deteriorated;(p)Customer A attended his GP on 28 May 2012 and further blood tests were ordered to check the Digoxin levels in Customer A’s body;(q)Customer A had further blood tests on 30 May 2012 which showed his Digoxin levels were still in the “high” range;(r)Due to his ingestion of Digoxin, Customer A required two weeks away from work on sick leave. He returned to work part-time on 4 June 2012;(s)On 4 June 2012, Customer A’s blood tests showed that his Digoxin levels had decreased to an almost “normal” level; (t)Customer A began dialysis on 6 June 2012; and(u)If Customer A had continued taking Digoxin as directed on the medication label and without medical intervention, his symptoms would have become much more acute and could have been fatal.